Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us nowIn 2023, Philips spent approximately 827 million euros on research and development in its diagnosis and treatment segment, the largest R&D expense among the company's segments. This was followed by 663 million euros spent in connected care.
You only have access to basic statistics.
This statistic is not included in your account.
Business Solutions including all features.
Global positioning
Key facts
Business distribution
Competitors
Miscellaneous
Further related statistics